Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study

References

• Ascoli, V., Cavone, D., Merler, E., Barbieri, P.G., Romeo, L., Nardi, F., and Musti, M. 2007. Mesothelioma in blood related subjects: Report of 11 clusters among 1954 Italy cases and review of the literature. Am. J. Ind. Med. 50: 357–369.
   PubMed Web of Science ®Google Scholar
• Aust, E. A., Lund, L. G., Chao, C. C., Park, S. H., and Fang, R. 2000. Role of iron in the cellular effects of asbestos. Inhal. Toxicol. 12(suppl. 3): 75–80.
   Google Scholar
• Aust, A. E., Cook, P. M., and Dodson, R. F. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J. Toxicol. Environ. Health B Crit. Rev. 14: 40–75.
   PubMed Web of Science ®Google Scholar
• Betti, M., Neri, M., Ferrante, D., Landi, S., Biava, A., Gemignani, F., Bertolotti, M., Mirabelli, D., Padoan, M., Ugolini, D., Botta, M., Bonassi, S., Magnani, C., and Dianzani, I. 2009. Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesothelioma. Int. J. Hyg Environ. Health 212: 322–329.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., Brollo, A., Ramani, L., and Berté, R. 1991. Exposure to asbestos in Monfalcone, Italy. A necropsy-based study. IARC Sci. Publ. 112: 127–140.
   PubMedGoogle Scholar
• Bianchi, C., Brollo, A., Ramani, L., and Zuch, C. 1993. Asbestos-related mesothelioma in Monfalcone, Italy. Am. J. Ind. Med. 24: 149–160.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., Brollo, A., Ramani, L., and Zuch, C. 1997. Pleural plaques as risk indicators for malignant pleural mesothelioma: A necropsy-based study. Am. J. Ind. Med. 32: 445–449.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., Brollo, A., Ramani, L., Bianchi, T., and Giarelli, L. 2001. Asbestos exposure in malignant mesothelioma of the pleura: A survey of 557 cases. Ind. Health. 39: 161–167.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., Brollo, A., Ramani, L., Bianchi, T., and Giarelli, L. 2004. Familial mesothelioma of the pleura—A report of 40 cases. Ind. Health 42: 235–239.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., and Bianchi, T. 2007. Malignant mesothelioma: Global incidence and relationship with asbestos. Ind. Health. 45: 379–387.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., Bianchi, T., and Tommasi, M. 2007. Long latency periods in asbestos-related mesothelioma of the pleura. Eur. J. Oncol. 12: 189–195.
   Google Scholar
• Bianchi, C., and Bianchi, T. 2009. Malignant pleural mesothelioma in Italy. Indian J. Occup. Environ. Med. 13: 80–83.
   PubMedGoogle Scholar
• Borelli, V., Brochetta, C., Melato, M., Rizzardi, C., Polentarutti. M., Busatto, C., Vita, F., Abbate, R., Gotter, R., and Zabucchi, G. 2007. A procedure for the isolation of asbestos bodies from lung tissue by exploiting their magnetic properties: A new approach to asbestos body study. J. Toxicol. Environ. Health A 70: 1232–1240.
   PubMed Web of Science ®Google Scholar
• Borelli, V., Moura, R. R., Trevisan, E., and Crovella. S. 2015. NLRP1 and NLRP3 polymorphisms in mesothelioma patients and asbestos exposed individuals, A population-based autopsy study from North East Italy. Infect. Agent Cancer 10: 26.
   PubMed Web of Science ®Google Scholar
• Cadby, G., Mukherjee, S., Musk, A. W., Reid, A., Garlepp, M., Dick, I., Robinson, C., Hui, J., Fiorito, G., Guarrera, S., Beilby, J., Melton, P. E., Moses, E. K., Ugolini, D., Mirabelli, D., Bonassi, S., Magnani, C., Dianzani, I., Matullo, G., Robinson, B., Creaney, J., and Palmer, L. J. 2013. A genome-wide association study for malignant mesothelioma risk. Lung Cancer 82: 1–8.
   PubMed Web of Science ®Google Scholar
• Carbone, M., Ly, B. H., Dodson, R. F., Pagano, I., Morris, P. T., Dogan, U. A., Gazdar, A. F., Pass, H. I., and Yang, H. 2012. Malignant mesothelioma: Facts, myths, and hypotheses. J. Cell. Physiol. 227: 44–58.
   PubMed Web of Science ®Google Scholar
• Casali, M., Carugno, M., Cattaneo, A., Consonni, D., Mensi, C., Genovese, U., Cavallo, D. M., Somigliana, A., and Pesatori, A. C. 2015. Asbestos lung burden in necroscopic samples from the general population of Milan, Italy. Ann. Occup. Hyg. 59: 909–921.
   PubMed Web of Science ®Google Scholar
• Chew, S. H., and Toyokuni, S. 2015. Malignant mesothelioma as an oxidative stress-induced cancer: An update. Free Radical Biol. Med. 86: 166–178.
   PubMed Web of Science ®Google Scholar
• de Klerk, N., Alfonso, H., Olsen, N., Reid, A., Sleith, J., Palmer, L., Berry, G., and Musk, A. B. 2013. Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia. Int. J. Cancer 132: 1423–1428.
   PubMed Web of Science ®Google Scholar
• Dianzani, L., Gibello, A., Biava, M., Giordano, M., Bertolotti, M., Betti, D., Ferrante, S., Guarrera, G. P., Betta, D., Mirabelli, G., Matullo, C., and Magnani, C. 2006. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res. 599: 124–134.
   PubMed Web of Science ®Google Scholar
• Gemignani, F., Neri, M., Bottari, F., Barale, R., Canessa, P. A., Canzian, F., Ceppi, M., Spitaleri, I., Cipollini, M., Ivaldi, G. P., Mencoboni, M., Scaruffi, P., Tonini, G. P., Ugolini, D., Mutti, L., Bonassi, S., and Landi, S. 2009. Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. Mutat. Res. 671: 76–83.
   PubMed Web of Science ®Google Scholar
• Ghio, A. J. 2009. Disruption of iron homeostasis and lung disease. Biochim. Biophys. Acta 1790: 731–739.
   PubMed Web of Science ®Google Scholar
• Ghio, A. J., Churg, A., and Roggli, V. L. 2004. Ferruginous bodies: Implications in the mechanism of fiber and particle toxicity. Toxicol. Pathol. 32: 643–649.
   PubMed Web of Science ®Google Scholar
• Ghio, A. J., Stonehuerner, J., Richards, J., and Devlin, R. B. 2008. Iron homeostasis in the lung following asbestos exposure. Antioxid. Redox Signal. 10: 371–377.
   PubMed Web of Science ®Google Scholar
• Ghio, A. J., Tan, R. J., Ghio, K., Fattman, C. L., and Oury, T. D. 2009. Iron accumulation and expression of iron-related proteins following murine exposure to crocidolite. J. Environ. Pathol. Toxicol. Oncol. 28: 153–162.
   PubMed Web of Science ®Google Scholar
• Girardelli, M., Maestri, I., Rinaldi, R.R., Tognon, M., Boldorini, R., Bovenzi, M., Crovella, S., and Comar, M. 2012. NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect. Agent Cancer 7: 25.
   PubMed Web of Science ®Google Scholar
• Hirvonen, S.T, Pelin, K., Tammilehto, L., Karjalainen, A., Mattson, K., and Linnainmaa, K. 1995. Inherited GSTM1, NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res. 55: 2981–2983.
   Google Scholar
• Hirvonen, S.T., Saarikoski, K., Linnainmaa, K., Koskinen, K., Husgafvel-Pursiainen, K., Mattson, H., and Vainio, H. 1996. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst. 88: 1853–1856.
   PubMed Web of Science ®Google Scholar
• Jiang, L., Akatsuka, S., Nagai, H., Chew, S.H., Ohara, H., Okazaki, Y., Yamashita, Y., Yoshikawa, Y., Yasui, H., Ikuta, K., Sasaki, K., Kohgo, Y., Hirano, S., Shinohara, Y., Kohyama, N., Takahashi, T., and Toyokuni, S. 2012. Iron overload signature in chrysotile-induced malignant mesothelioma. J. Pathol. 228: 366–377.
   PubMed Web of Science ®Google Scholar
• Jiang, R., Hua, C., Wan, Y., Jiang, B., Hu, H., Zheng, J., Fuqua, B. K., Dunaief, J. L., Anderson, G. J., David, S., Vulpe, C. D., and Chen, H. 2015. Hephaestin and ceruloplasmin play distinct but interrelated roles in iron homeostasis in mouse brain. J. Nutr. 145: 1003–1009.
   PubMed Web of Science ®Google Scholar
• Kane, A. B. 2003 Asbestos bodies: Clues to the mechanism of asbestos toxicity? Hum. Pathol. 34: 735–736.
   PubMed Web of Science ®Google Scholar
• Klopfleisch, R., Weiss, A.T., and Gruber, A.D. 2011. Excavation of a buried treasure-DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol. Histopathol. 26: 797–810.
   Google Scholar
• Landi, S., Gemignani, F., Neri, M., Barale, R., Bonassi, S., Bottari, F., Canessa, P.A., Canzian, F., Ceppi, M., Filiberti, R., Ivaldi, G.P., Mencoboni, M., Scaruf, P., Tonini, G.P., Mutti, L., and Puntoni, R. 2007. Polymorphisms of glutathione-S-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int. J. Cancer 120: 2739–2743.
   PubMed Web of Science ®Google Scholar
• Lewis, C. M., and Knight, J. 2012. Introduction to genetic association studies. Cold Spring Harbor Protocol 2012: 297–306
   PubMedGoogle Scholar
• Liu, G., Cheresh, P., and Kamp, D. W. 2013. Molecular basis of asbestos-induced lung disease. Annu. Rev. Pathol. 8: 161–187.
   PubMed Web of Science ®Google Scholar
• London, S. J., Daly, A. K., Cooper, J., Navidi, W. C., Carpenter, C. L., and Idle, J. R. 1995. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J. Natl. Cancer Inst. 87: 1246–1253.
   PubMed Web of Science ®Google Scholar
• Matullo, G., Guarrera, S., Betti, M., Fiorito, G., Ferrante, D., Voglino, F., Cadby, G., Di Gaetano, C., Rosa, F., Russo, A., Hirvonen, A., Casalone, E., Tunesi, S., Padoan, M., Giordano, M., Aspesi, A., Casadio, C., Ardissone, F., Ruffini, E., Betta, P. G., Libener, R., Guaschino, R., Piccolini, E., Neri, M., Musk, A. W., de Klerk, N. H., Hui, J., Beilby, J., James, A. L., Creaney, J., Robinson, B. W., Mukherjee, S., Palmer, L. J., Mirabelli, D., Ugolini, D., Bonassi, S., Magnani, C., and Dianzani, I. 2013. Genetic variants associated with increased risk of malignant pleural mesothelioma: A genome-wide association study. PLoS ONE 10: e0130109.
   Google Scholar
• Miller, S. A., Dykes, D. D., and Polesky, H. F. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
   PubMed Web of Science ®Google Scholar
• Mossman, B. T., Lippmann, M., Hesterberg, T. W., Kelsey, K. T., Barchowsky, A., and Bonner, J. C. 2011. Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J. Toxicol. Environ. Health B Crit. Rev. 14:76–121.
   PubMed Web of Science ®Google Scholar
• Murakami, A., Fujimori, Y., Yoshikawa, Y., Yamada, S., Tamura, K., Hirayama, N., Terada, T., Kuribayashi, K., Tabata, C., Fukuoka, K., Tamaoki, T., and Nakano, T. 2012. Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma. Lung 190: 333–337.
   PubMed Web of Science ®Google Scholar
• Neri, M., Filiberti, R., Taioli, E., Garte, S., Paracchini, V., Bolognesi, C., Canessa, P. A., Fontana, V., Ivaldi, G. P., Verna, A., Bonassi, S., and Puntoni, R. 2005. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat. Res. 592: 36–44.
   PubMed Web of Science ®Google Scholar
• Neri, M., Taioli, E., Filiberti, R., Ivaldi, G. P., Canessa, P.A., Verna, A., Marroni, P., Puntoni, R., Hirvonen, A., and Garte, S. 2006. Metabolic genotypes as modulators of asbestos related pleural malignant mesothelioma risk: A comparison of Finnish and Italian populations. Int. J. Hyg. Environ. Health 209: 393–398.
   PubMed Web of Science ®Google Scholar
• Neri, M., Ugolini, D., Dianzani, I., Gemignani, F., Landi, S., Cesario, A., Magnani, C., Mutti, L., Puntoni, R., and Bonassi, S. 2008. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat. Res. 659: 126–136.
   PubMed Web of Science ®Google Scholar
• Puntoni, R., Filiberti, R., Cerrano, P.G., Neri, M., Andreatta, R., and Bonassi, S. 2003. Implementation of a molecular epidemiology approach to human pleural malignant mesothelioma. Mutat. Res. 544: 385–396.
   PubMed Web of Science ®Google Scholar
• Smith, N. J., and Naylor, B. 1972 A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am. J. Clin. Pathol. 58: 250–254.
   PubMed Web of Science ®Google Scholar
• Testa, J. R., Cheung, M., Pei, J., Below, J. E., Tan, Y., Sementino, E., Cox, N. J., Dogan, A. U., Pass, H. I., Trusa, S., Hesdorffer, M., Nasu, M., Powers, A., Rivera, Z., Comertpay, S., Tanji, M., Gaudino, G., Yang, H., and Carbone, M. 2011. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43: 1022–1025.
   PubMed Web of Science ®Google Scholar
• Toyokuni, S. 2011. Iron as a target of chemoprevention for longevity in humans. Free Radical Res. 45: 906–917.
   PubMed Web of Science ®Google Scholar
• Turi, J. L., Yang, F., Garrick, M. D., Piantadosi, C. A., and Ghio, A. J. 2004. The iron cycle and oxidative stress in the lung. Free Radical Biol. Med. 36: 850–857.
   PubMed Web of Science ®Google Scholar
• Ugolini, D., Neri, M., Ceppi, M., Cesario A, Dianzani, I., Filiberti, R, Gemignani, F., Landi, S., Magnani, C., Mutti, L., Puntoni, R., and Bonassi, S. 2008. Genetic susceptibility to malignant mesothelioma and exposure to asbestos: The influence of the familial factor. Mutat. Res. 658: 162–171.
   PubMed Web of Science ®Google Scholar